<DOC>
	<DOCNO>NCT02394821</DOCNO>
	<brief_summary>For odor control malignant wound ( MW ) , use 0.8 % metronidazole solution - second recommendation scientific clinical practice . But formulation available Brazil , application nursing steep metronidazole tablet , dilute saline apply bed ( MW ) . Thus , use label metronidazole ( tablet orally apply via `` topical `` - intact skin mucosa ) , nurse eventually manipulate solution bedside , law power pharmacist bedside take . Family antiseptic chlorhexidine develop purpose use infect wound call polihexanide ( PHMB ) . In Brazil available hospital home care ( 0.2 % Aquasept ® ) use . Evidence report positive result control infection chronic wound pressure ulcer . Although tested efficacy odor control . Thus study aim compare metronidazole solution 0.8 % versus 0.2 % PHMB odor control , , result favorable PHMB treatment option odor control ready use formulation easy access . Evaluate compare effectiveness metronidazole solution 0.8 % polihexanide solution ( PHMB ) odor control MW . Aims : Evaluate compare time need odor control ( reduction day ) , use metronidazole PHMB MW ( primary endpoint ) ; Evaluate compare perception patient , nurse researcher odor MW , use metronidazole PHMB MW ; Evaluate compare pain report patient dress change , use metronidazole PHMB MW ; Evaluate compare quality life patient use metronidazole PHMB MW . This randomized , double -blind study patient diagnose cancer patient MW odor clinical trial . The sample consist 24 subject divide 2 group ( control - metronidazole group experimental group - PHMB ) , recruit one cancer hospital city São Paulo ( AC Camargo Cancer Center ) , protocol description odor control MW metronidazole . After acceptance subject return Statement Informed Consent sign , randomization do . For blinding , 0.8 % metronidazole solution provide compound pharmacy ( stability test tablet dilute - stipulate expiration date ) , PHMB buy supplier , deliver compound pharmacy store PHMB identical bottle metronidazole ( responsible researcher know group subject randomize ) . The evaluation odor take 3 `` employee `` patient 3 scale zero , four , eight twelve day ( early classify `` odorless `` 3 reviewer patient ) . Two scale painful sensation exchange healing , one quality life apply patient specifically impact odor subject 's life . To meet proposed objective , data analyze : Friedman test ass odor reduction respect time ; Mann-Whitney ( test ) comparison group Fisher exact test compare proportion . Data present form frequency table categorical variable mean , standard deviation position measurement quantitative variable . Will also perform non-parametric analysis ordinal data , parametric analysis Generalized Estimation Equation binomial variable , depend data distribution sample size .</brief_summary>
	<brief_title>Odor Management Fungating Wounds Comparing Metronidazole Polihexanide</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Age ≥ 18 year . Diagnosis malignat wound odor , regardless location , etiology tumor staging ; well treatment palliative care . Confirmation participation study sign Instrument Consent , personally responsible caretaker smell</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>